Waters Corporation
Waters Corporation (WAT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · WAT · as of Jun 8, 2026
Key Statistics
Explore Waters Corporation Data
wat stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 35 · Buy rate: 34.3%
The WAT analyst consensus is Hold, based on ratings from 35 Wall Street analysts over the past 3 months. The average 12-month price target is $406.33, representing +11.21% upside from the current price of $365.36.
Competitors & Peers
wat competitorsWAT
DGX
DXCM
ILMN
INCY
LHStock Performance
Full HistoryAbout Waters Corporation
Waters Corporation a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, man…
what is waters corporation · wat stock overview · waters corporation company profile · who is waters corporation ceo · wat NYSE · waters corporation headquarters · waters corporation business segments
About Stock Overview & Key Data
Waters Corporation (WAT) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Nov 17, 1995. As of the latest trading session, WAT stock price is $365.36, with a market capitalization of $23.8B. The stock has returned +4.89% over the past 12 months and -3.81% year-to-date.
According to 35 Wall Street analysts, the consensus rating for Waters Corporation stock is Hold, with an average 12-month price target of $406.33. In fiscal year 2025, Waters Corporation reported revenue of $3.2B and net income of $642.6M. For detailed data — including Waters Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Waters Corporation (WAT) stock price is $365.36. The stock is traded on NYSE under the ticker symbol WAT. The 52-week range is $275.05 – $414.15.